ArticleJournal of thoracic disease2026
Incidental pulmonary nodules detected on computed tomography pulmonary angiography: prevalence and malignancy outcomes from a Thai tertiary-care center.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography pulmonary angiography (CTPA) is widely used for diagnosing pulmonary embolism (PE) and frequently reveals incidental pulmonary nodules. However, data regarding the prevalence and malignant outcomes of incidental pulmonary nodules, particularly among patients with PE, remain limited in Thailand. This study aimed to investigate the prevalence of incidental pulmonary nodules detected on CTPA and to evaluate malignancy outcomes, particularly in patients with concurrent PE. Methods: This retrospective cohort study included patients aged ≥18 years who underwent CTPA at King Chulalongkorn Memorial Hospital between January 2017 and December 2018. Patients with active lung cancer or known pulmonary metastases were excluded. Clinical characteristics, CTPA findings, and follow-up data were reviewed. Pulmonary nodules were followed until a definitive diagnosis was established, until May 2024, or for a minimum of 2 years in the absence of interval growth. Results: A total of 376 patients were included in the analysis. Incidental pulmonary nodules were identified in 129 patients (34.3%), while PE was diagnosed in 110 patients (29.3%). The prevalence of incidental pulmonary nodules did not differ significantly between the PE-positive and PE-negative groups (29.1% Conclusions: The prevalence of incidental pulmonary nodules detected on CTPA were common and occurred more frequently than previously reported in several international studies. Patients with concurrent PE were more likely to have pulmonary nodules >8 mm and malignant outcomes than patients without PE. These findings suggest that incidental pulmonary nodules detected in patients with concomitant PE may identify a subgroup warranting careful clinical follow-up. Because of the retrospective design and limited number of malignant outcomes, larger prospective studies are required before changes to current surveillance strategies can be recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.